 <h1>Xanax XR Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>alprazolam</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about alprazolam. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Xanax XR.</p><h2>In Summary</h2><p><b>Common side effects of Xanax XR include:</b> depression, diarrhea, drowsiness, dysarthria, headache, insomnia, memory impairment, nervousness, sedated state, and tremor. <b>Other side effects include:</b> anxiety, ataxia, constipation, depersonalization, hyperventilation, hypoesthesia, muscle twitching, paresthesia, weight loss, decreased appetite, and decreased libido.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to alprazolam: oral solution, oral tablet, oral tablet disintegrating, oral tablet extended release</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing for patients with inadequate treatment options. Limit dosages and durations to the minimum required and follow patients for signs and symptoms of respiratory depression and sedation.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, alprazolam (the active ingredient contained in Xanax XR) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking alprazolam:</p><p>
<i>More common</i>
</p><ul>
<li>Being forgetful</li>
<li>changes in patterns and rhythms of speech</li>
<li>clumsiness or unsteadiness</li>
<li>difficulty with coordination</li>
<li>discouragement</li>
<li>drowsiness</li>
<li>feeling sad or empty</li>
<li>irritability</li>
<li>lack of appetite</li>
<li>lightheadedness</li>
<li>loss of interest or pleasure</li>
<li>relaxed and calm</li>
<li>shakiness and unsteady walk</li>
<li>sleepiness or unusual drowsiness</li>
<li>slurred speech</li>
<li>tiredness</li>
<li>trouble concentrating</li>
<li>trouble performing routine tasks</li>
<li>trouble sleeping</li>
<li>trouble speaking</li>
<li>unsteadiness, trembling, or other problems with muscle control or coordination</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>blurred vision</li>
<li>body aches or pain</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles, or tingling feelings</li>
<li>changes in behavior</li>
<li>chills</li>
<li>clay-colored stools</li>
<li>confusion about identity, place, and time</li>
<li>cough</li>
<li>dark urine</li>
<li>decrease in frequency of urination</li>
<li>decrease in urine volume</li>
<li>diarrhea</li>
<li>difficult or labored breathing</li>
<li>difficulty in passing urine (dribbling)</li>
<li>difficulty with concentration</li>
<li>difficulty with moving</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>dry mouth</li>
<li>ear congestion</li>
<li>environment seems unreal</li>
<li>fainting</li>
<li>fear or nervousness</li>
<li>feeling of unreality</li>
<li>feeling warm</li>
<li>fever</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>hyperventilation</li>
<li>inability to move the eyes</li>
<li>inability to sit still</li>
<li>increased blinking or spasms of the eyelid</li>
<li>irregular heartbeats</li>
<li>itching or rash</li>
<li>joint pain</li>
<li>lack or loss of self-control</li>
<li>loss of bladder control</li>
<li>loss of coordination</li>
<li>loss of memory</li>
<li>loss of voice</li>
<li>mood or mental changes</li>
<li>muscle aching or cramping</li>
<li>muscle pain or stiffness</li>
<li>muscle weakness</li>
<li>nasal congestion</li>
<li>nausea</li>
<li>need to keep moving</li>
<li>painful urination</li>
<li>problems with memory</li>
<li>restlessness</li>
<li>runny nose</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>seizures</li>
<li>sense of detachment from self or body</li>
<li>shaking</li>
<li>shivering</li>
<li>sneezing</li>
<li>sore throat</li>
<li>sticking out of the tongue</li>
<li>sweating</li>
<li>swollen joints</li>
<li>talkativeness</li>
<li>tightness in the chest</li>
<li>trouble with balance</li>
<li>twitching, twisting, or uncontrolled repetitive movements of the tongue, lips, face, arms, or legs</li>
<li>uncontrolled twisting movements of the neck, trunk, arms, or legs</li>
<li>unpleasant breath odor</li>
<li>unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness</li>
<li>unusual facial expressions</li>
<li>unusually deep sleep</li>
<li>unusually long duration of sleep</li>
<li>vomiting of blood</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Actions that are out of control</li>
<li>attack, assault, or force</li>
<li>chest pain</li>
<li>continuing ringing or buzzing or other unexplained noise in the ears</li>
<li>decreased awareness or responsiveness</li>
<li>deep or fast breathing with dizziness</li>
<li>ear pain</li>
<li>false or unusual sense of well-being</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>feeling jittery</li>
<li>feeling unusually cold</li>
<li>generalized slowing of mental and physical activity</li>
<li>hearing loss</li>
<li>hoarseness</li>
<li>lack of feeling or emotion</li>
<li>loss of control of the legs</li>
<li>loss of strength or energy</li>
<li>nightmares</li>
<li>numbness of the feet, hands, and around mouth</li>
<li>severe sleepiness</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>sleep talking</li>
<li>swelling</li>
<li>talking, feeling, and acting with excitement</li>
<li>thoughts of killing oneself</li>
<li>uncaring</li>
<li>unusual weak feeling</li>
<li>voice changes</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>General tiredness and weakness</li>
<li>light-colored stools</li>
<li>stomach pain, continuing</li>
<li>upper right abdominal or stomach pain</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of alprazolam may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Absent, missed, or irregular menstrual periods</li>
<li>decreased appetite</li>
<li>decreased interest in sexual intercourse</li>
<li>decreased sexual performance or desire abnormal ejaculation</li>
<li>difficulty having a bowel movement (stool)</li>
<li>inability to have or keep an erection</li>
<li>increased appetite</li>
<li>increased in sexual ability, desire, drive, or performance</li>
<li>increased interest in sexual intercourse</li>
<li>increased weight</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>stopping of menstrual bleeding</li>
<li>watering of the mouth</li>
<li>weight loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abdominal or bloating and cramping</li>
<li>blistering, crusting, irritation, itching, or reddening of the skin</li>
<li>change in taste bad unusual or unpleasant (after) taste</li>
<li>cracked, dry, or scaly skin</li>
<li>cramps</li>
<li>double vision</li>
<li>feeling of warmth</li>
<li>heavy bleeding</li>
<li>menstrual changes</li>
<li>pain</li>
<li>pelvic pain</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>seeing double</li>
<li>sudden sweating</li>
<li>unexplained runny nose or sneezing</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>bigger, dilated, or enlarged pupils (black part of the eye)</li>
<li>change in color vision</li>
<li>difficulty seeing at night</li>
<li>feeling of constant movement of self or surroundings</li>
<li>feeling of relaxation</li>
<li>heartburn</li>
<li>hives or welts</li>
<li>increased sensitivity of the eyes to sunlight</li>
<li>indigestion</li>
<li>redness of the skin</li>
<li>runny nose</li>
<li>sensation of spinning</li>
<li>stomach discomfort, upset, or pain</li>
<li>stuffy nose</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>red, irritated eyes</li>
<li>red skin lesions, often with a purple center</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>swelling of the breasts or breast soreness in both females and males</li>
<li>unexpected or excess milk flow from the breasts</li>
</ul><p>
<!-- end oral solution, oral tablet, oral tablet disintegrating, oral tablet extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to alprazolam: compounding powder, oral concentrate, oral solution, oral tablet, oral tablet disintegrating, oral tablet extended release</i></p><h3>General</h3><p>Immediate-release formulations: The most commonly reported side effects included drowsiness/sedation, fatigue and tiredness, impaired coordination, memory impairment, and irritability.</p>
<p></p>
<p>Extended-release tablets: The most commonly reported side effects included sedation, tremor, headache, insomnia, and somnolence.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Immediate-release formulations:</p>
<p><b>Very common</b> (10% or more): Sedation (up to 77%), drowsiness (up to 76.8%), impaired coordination (up to 40.1%), memory impairment (up to 33.1%), dizziness (up to 29.8%), lightheadedness (up to 29.8%), headache (up to 29.2%), cognitive disorder (up to 29%), dysarthria (up to 23.3%), abnormal voluntary movement (up to 17.3%)</p>
<p><b>Common</b> (1% to 10%): Abnormal coordination, akathisia, ataxia, attention disturbance, balance disorder, hypersomnia, lethargy, paresthesia, somnolence, syncope, tremor, vasomotor disturbances</p>
<p><b>Uncommon</b> (0.1% to 1%): Amnesia, autonomic manifestations, coordination disorders, intellectual impairment, stimulation</p>
<p><b>Frequency not reported</b>: Concentration difficulties, convulsions, dystonia, loss of coordination, seizures, sleepiness, slurred speech, taste alterations, transient amnesia, withdrawal seizures</p>
<p><b>Postmarketing reports</b>: Autonomic nervous system imbalance, psychomotor hyperactivity</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Very common</b> (10% or more): Sedation (up to 45.2%), tremor (up to 28.2%), headache (up to 26.5%), somnolence (up to 23%), memory impairment (up to 15.4%), dysarthria (up to 10.9%)</p>
<p><b>Common</b> (1% to 10%): Abnormal coordination, ataxia, balance impaired, disturbance in attention, dizziness, dyskinesia, hypersomnia, hypoesthesia, lethargy, mental impairment, paresthesia, vertigo</p>
<p><b>Uncommon</b> (0.1% to 1%): Amnesia, clumsiness, depressed level of consciousness, hangover, hypotonia, stupor, syncope</p>
<p><b>Frequency not reported</b>: Stimulation, withdrawal seizures<sup>[Ref]</sup></p><h3>Other</h3><p>Immediate-release formulations:</p>
<p><b>Very common</b> (10% or more): Fatigue and tiredness (up to 49%)</p>
<p><b>Common</b> (1% to 10%): Feeling warm, tinnitus, weakness</p>
<p><b>Frequency not reported</b>: Rebound phenomena</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Very common</b> (10% or more): Fatigue (up to 13.9%)</p>
<p><b>Common</b> (1% to 10%): Malaise, road traffic accident, weakness</p>
<p><b>Uncommon</b> (0.1% to 1%): Asthenia, ear pain, fall, feeling drunk, feeling hot and cold, feeling jittery, feeling of relaxation, increased energy, loss of control of legs, pyrexia, rigors, sluggishness, tinnitus</p>
<p><b>Frequency not reported</b>: Paradoxical reactions<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Immediate-release formulations:</p>
<p><b>Very common</b> (10% or more): Irritability (up to 33.1%), insomnia (up to 29.5%), anxiety (up to 19.2%), decreased libido (up to 14%), depression (up to 13.9%), confusional state (up to 10.4%)</p>
<p><b>Common</b> (1% to 10%): Agitation, change in libido (not specified), confusion, derealization, disinhibition, disorientation, dream abnormalities, fear, increased libido, nervousness, talkativeness</p>
<p><b>Uncommon</b> (0.1% to 1%): Adverse behavioral effects, altered mood, concentration difficulties, hallucinations</p>
<p><b>Rare</b> (0.01% to 0.1%): Hypomania, mania, other adverse behavioral effects</p>
<p><b>Frequency not reported</b>: Abuse, aggressive or hostile behavior, aggressiveness/aggression, anterograde amnesia, delusion, depersonalization, dysphoria/mild dysphoria, hostility, inappropriate behavior, intrusive thoughts, nightmares, physical dependence, primary/secondary major depressive disorders, psychic dependence, psychoses, rage, restlessness, suicide, withdrawal symptoms</p>
<p><b>Postmarketing reports</b>: Abnormal thinking, anger, libido disorder</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Very common</b> (10% or more): Insomnia (up to 24.2%), nervousness (up to 21.8%), depression (up to 12.1%)</p>
<p><b>Common</b> (1% to 10%): Agitation, anxiety, confusion, depersonalization, depressed mood, derealization, disorientation, irritability, libido decreased/increased, nightmare, restlessness</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal dreams, aggression, anger, apathy, bradyphrenia, euphoric mood, hallucination, homicidal ideation, hypomania, impulse control, logorrhea, mania, mood swings, psychomotor retardation, sleep talking, suicidal ideation</p>
<p><b>Frequency not reported</b>: Adverse behavioral effects, aggressive/hostile behavior, hostility, intrusive thoughts, other adverse behavioral effects, sleep disturbances, rage, withdrawal syndrome<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Immediate-release formulations:</p>
<p><b>Very common</b> (10% or more): Decreased salivation (up to 32.8%), constipation (up to 26.2%), nausea (up to 22%), vomiting (up to 22%), diarrhea (up to 20.6%), abdominal distress (up to 18.3%), dry mouth (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Increased salivation</p>
<p><b>Uncommon</b> (0.1% to 1%): Gastrointestinal symptoms/various gastrointestinal symptoms</p>
<p><b>Frequency not reported</b>: Abdominal cramps</p>
<p><b>Postmarketing reports</b>: Gastrointestinal disorder</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Very common</b> (10% or more): Diarrhea (up to 12.1%), dry mouth (up to 10.2%)</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, constipation, dyspepsia, nausea, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Dysphagia, salivary hypersecretion</p>
<p><b>Postmarketing reports</b>: Gastrointestinal disorder<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Immediate-release formulations:</p>
<p><b>Very common</b> (10% or more): Increased appetite (up to 33%), decreased appetite (up to 28%), weight gain (up to 27%), weight loss (up to 23%)</p>
<p><b>Frequency not reported</b>: Anorexia</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Common</b> (1% to 10%): Anorexia, appetite decreased/increased, weight decreased/increased</p>
<p><b>Uncommon</b> (0.1% to 1%): Thirst<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Immediate-release formulations:</p>
<p><b>Very common</b> (10% or more): Tachycardia (up to 15.4%), chest pain (up to 10.6%)</p>
<p><b>Common</b> (1% to 10%): Edema, hypotension, palpitations</p>
<p><b>Postmarketing reports</b>: Peripheral edema</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Common</b> (1% to 10%): Chest pain, hot flush, palpitations</p>
<p><b>Uncommon</b> (0.1% to 1%): Chest tightness, edema, hypotension, sinus tachycardia</p>
<p><b>Postmarketing reports</b>: Peripheral edema<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Immediate-release formulations:</p>
<p><b>Very common</b> (10% or more): Micturition difficulties (up to 12.2%), menstrual disorders (up to 10.4%)</p>
<p><b>Common</b> (1% to 10%): Incontinence, sexual dysfunction</p>
<p><b>Frequency not reported</b>: Menstrual irregularities, urinary retention</p>
<p><b>Postmarketing reports</b>: Galactorrhea</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Common</b> (1% to 10%): Difficulty in micturition, dysmenorrhea, premenstrual syndrome, sexual dysfunction</p>
<p><b>Uncommon</b> (0.1% to 1%): Urinary frequency, urinary incontinence</p>
<p><b>Postmarketing reports</b>: Galactorrhea<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Immediate-release formulations:</p>
<p><b>Very common</b> (10% or more): Sweating (up to 15.1%), rash (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Dermatitis</p>
<p><b>Frequency not reported</b>: Pruritus</p>
<p><b>Postmarketing reports</b>: Photosensitivity reaction, Stevens-Johnson syndrome</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Common</b> (1% to 10%): Pruritus, sweating increased</p>
<p><b>Uncommon</b> (0.1% to 1%): Clamminess, rash, urticaria</p>
<p><b>Postmarketing reports</b>: Stevens-Johnson syndrome<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Immediate-release formulations:</p>
<p><b>Very common</b> (10% or more): Nasal congestion (up to 17.4%)</p>
<p><b>Common</b> (1% to 10%): Hyperventilation, upper respiratory tract infection</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Common</b> (1% to 10%): Allergic rhinitis, dyspnea, hyperventilation, nasal congestion, pharyngolaryngeal pain, upper respiratory tract infections</p>
<p><b>Uncommon</b> (0.1% to 1%): Choking sensation, dysphonia, epistaxis, rhinorrhea, sleep apnea syndrome<sup>[Ref]</sup></p><h3>Ocular</h3><p>Immediate-release formulations:</p>
<p><b>Very common</b> (10% or more): Blurred vision (up to 21%)</p>
<p><b>Rare</b> (0.01% to 0.1%): Increased intraocular pressure</p>
<p><b>Frequency not reported</b>: Diplopia</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Common</b> (1% to 10%): Blurred vision</p>
<p><b>Uncommon</b> (0.1% to 1%): Mydriasis, photophobia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Immediate-release formulations:</p>
<p><b>Common</b> (1% to 10%): Muscle stiffness, muscle tone disorders, muscular cramps, muscular twitching, rigidity</p>
<p><b>Uncommon</b> (0.1% to 1%): Muscular weakness</p>
<p><b>Frequency not reported</b>: Musculoskeletal weakness</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Common</b> (1% to 10%): Arthralgia, back pain, muscle cramps, muscle twitching, myalgia, pain in limb</p>
<p><b>Frequency not reported</b>: Increased muscle spasticity<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Immediate-release formulations:</p>
<p><b>Common</b> (1% to 10%): Infection</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Immediate-release formulations:</p>
<p><b>Common</b> (1% to 10%): Allergy</p>
<p><b>Postmarketing reports</b>: Angioedema</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Immediate-release formulations:</p>
<p><b>Rare</b> (0.01% to 0.1%): Abnormal hepatic function tests, jaundice</p>
<p><b>Frequency not reported</b>: Elevated bilirubin, elevated hepatic enzymes</p>
<p><b>Postmarketing reports</b>: Hepatic failure, hepatitis</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Postmarketing reports</b>: Hepatic failure, hepatitis, liver enzyme elevations<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Immediate-release formulations:</p>
<p><b>Postmarketing reports</b>: Gynecomastia, hyperprolactinemia</p>
<p></p>
<p>Extended-release tablets:</p>
<p><b>Postmarketing reports</b>: Gynecomastia, hyperprolactinemia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Niravam (alprazolam)." Schwarz Pharma, Mequon, WI. </p><p id="ref_2">2. "Product Information. Xanax (alprazolam)." Pharmacia and Upjohn, Kalamazoo, MI. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_5">5. "Product Information. Xanax XR (alprazolam)." Pfizer U.S. Pharmaceuticals Group, New York, NY. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>How long does Xanax last for / stay in your system?</li>
<li>Klonopin vs Xanax - How are they different?</li>
<li>How long does Xanax XR take to start working, and how long does it stay in your system?</li>
<li>What is Farmapram called in the US?</li>
<li>Ativan vs Xanax - What is the difference?</li>
<li>What does extended release (ER) mean?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Xanax XR (alprazolam)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>40 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: benzodiazepines</li>
<li>FDA Alerts (3)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Xanax XR Oral &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Niravam</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Xanax</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Panic Disorder</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to alprazolam: compounding powder, oral concentrate, oral solution, oral tablet, oral tablet disintegrating, oral tablet extended release</i></p><h3>General</h3><p>Immediate-release formulations: The most commonly reported side effects included drowsiness/sedation, fatigue and tiredness, impaired coordination, memory impairment, and irritability.</p><p></p><p>Extended-release tablets: The most commonly reported side effects included sedation, tremor, headache, insomnia, and somnolence.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Immediate-release formulations:</p><p><b>Very common</b> (10% or more): Sedation (up to 77%), drowsiness (up to 76.8%), impaired coordination (up to 40.1%), memory impairment (up to 33.1%), dizziness (up to 29.8%), lightheadedness (up to 29.8%), headache (up to 29.2%), cognitive disorder (up to 29%), dysarthria (up to 23.3%), abnormal voluntary movement (up to 17.3%)</p><p><b>Common</b> (1% to 10%): Abnormal coordination, akathisia, ataxia, attention disturbance, balance disorder, hypersomnia, lethargy, paresthesia, somnolence, syncope, tremor, vasomotor disturbances</p><p><b>Uncommon</b> (0.1% to 1%): Amnesia, autonomic manifestations, coordination disorders, intellectual impairment, stimulation</p><p><b>Frequency not reported</b>: Concentration difficulties, convulsions, dystonia, loss of coordination, seizures, sleepiness, slurred speech, taste alterations, transient amnesia, withdrawal seizures</p><p><b>Postmarketing reports</b>: Autonomic nervous system imbalance, psychomotor hyperactivity</p><p></p><p>Extended-release tablets:</p><p><b>Very common</b> (10% or more): Sedation (up to 45.2%), tremor (up to 28.2%), headache (up to 26.5%), somnolence (up to 23%), memory impairment (up to 15.4%), dysarthria (up to 10.9%)</p><p><b>Common</b> (1% to 10%): Abnormal coordination, ataxia, balance impaired, disturbance in attention, dizziness, dyskinesia, hypersomnia, hypoesthesia, lethargy, mental impairment, paresthesia, vertigo</p><p><b>Uncommon</b> (0.1% to 1%): Amnesia, clumsiness, depressed level of consciousness, hangover, hypotonia, stupor, syncope</p><p><b>Frequency not reported</b>: Stimulation, withdrawal seizures<sup>[Ref]</sup></p><h3>Other</h3><p>Immediate-release formulations:</p><p><b>Very common</b> (10% or more): Fatigue and tiredness (up to 49%)</p><p><b>Common</b> (1% to 10%): Feeling warm, tinnitus, weakness</p><p><b>Frequency not reported</b>: Rebound phenomena</p><p></p><p>Extended-release tablets:</p><p><b>Very common</b> (10% or more): Fatigue (up to 13.9%)</p><p><b>Common</b> (1% to 10%): Malaise, road traffic accident, weakness</p><p><b>Uncommon</b> (0.1% to 1%): Asthenia, ear pain, fall, feeling drunk, feeling hot and cold, feeling jittery, feeling of relaxation, increased energy, loss of control of legs, pyrexia, rigors, sluggishness, tinnitus</p><p><b>Frequency not reported</b>: Paradoxical reactions<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Immediate-release formulations:</p><p><b>Very common</b> (10% or more): Irritability (up to 33.1%), insomnia (up to 29.5%), anxiety (up to 19.2%), decreased libido (up to 14%), depression (up to 13.9%), confusional state (up to 10.4%)</p><p><b>Common</b> (1% to 10%): Agitation, change in libido (not specified), confusion, derealization, disinhibition, disorientation, dream abnormalities, fear, increased libido, nervousness, talkativeness</p><p><b>Uncommon</b> (0.1% to 1%): Adverse behavioral effects, altered mood, concentration difficulties, hallucinations</p><p><b>Rare</b> (0.01% to 0.1%): Hypomania, mania, other adverse behavioral effects</p><p><b>Frequency not reported</b>: Abuse, aggressive or hostile behavior, aggressiveness/aggression, anterograde amnesia, delusion, depersonalization, dysphoria/mild dysphoria, hostility, inappropriate behavior, intrusive thoughts, nightmares, physical dependence, primary/secondary major depressive disorders, psychic dependence, psychoses, rage, restlessness, suicide, withdrawal symptoms</p><p><b>Postmarketing reports</b>: Abnormal thinking, anger, libido disorder</p><p></p><p>Extended-release tablets:</p><p><b>Very common</b> (10% or more): Insomnia (up to 24.2%), nervousness (up to 21.8%), depression (up to 12.1%)</p><p><b>Common</b> (1% to 10%): Agitation, anxiety, confusion, depersonalization, depressed mood, derealization, disorientation, irritability, libido decreased/increased, nightmare, restlessness</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal dreams, aggression, anger, apathy, bradyphrenia, euphoric mood, hallucination, homicidal ideation, hypomania, impulse control, logorrhea, mania, mood swings, psychomotor retardation, sleep talking, suicidal ideation</p><p><b>Frequency not reported</b>: Adverse behavioral effects, aggressive/hostile behavior, hostility, intrusive thoughts, other adverse behavioral effects, sleep disturbances, rage, withdrawal syndrome<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Immediate-release formulations:</p><p><b>Very common</b> (10% or more): Decreased salivation (up to 32.8%), constipation (up to 26.2%), nausea (up to 22%), vomiting (up to 22%), diarrhea (up to 20.6%), abdominal distress (up to 18.3%), dry mouth (up to 15%)</p><p><b>Common</b> (1% to 10%): Increased salivation</p><p><b>Uncommon</b> (0.1% to 1%): Gastrointestinal symptoms/various gastrointestinal symptoms</p><p><b>Frequency not reported</b>: Abdominal cramps</p><p><b>Postmarketing reports</b>: Gastrointestinal disorder</p><p></p><p>Extended-release tablets:</p><p><b>Very common</b> (10% or more): Diarrhea (up to 12.1%), dry mouth (up to 10.2%)</p><p><b>Common</b> (1% to 10%): Abdominal pain, constipation, dyspepsia, nausea, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Dysphagia, salivary hypersecretion</p><p><b>Postmarketing reports</b>: Gastrointestinal disorder<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Immediate-release formulations:</p><p><b>Very common</b> (10% or more): Increased appetite (up to 33%), decreased appetite (up to 28%), weight gain (up to 27%), weight loss (up to 23%)</p><p><b>Frequency not reported</b>: Anorexia</p><p></p><p>Extended-release tablets:</p><p><b>Common</b> (1% to 10%): Anorexia, appetite decreased/increased, weight decreased/increased</p><p><b>Uncommon</b> (0.1% to 1%): Thirst<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Immediate-release formulations:</p><p><b>Very common</b> (10% or more): Tachycardia (up to 15.4%), chest pain (up to 10.6%)</p><p><b>Common</b> (1% to 10%): Edema, hypotension, palpitations</p><p><b>Postmarketing reports</b>: Peripheral edema</p><p></p><p>Extended-release tablets:</p><p><b>Common</b> (1% to 10%): Chest pain, hot flush, palpitations</p><p><b>Uncommon</b> (0.1% to 1%): Chest tightness, edema, hypotension, sinus tachycardia</p><p><b>Postmarketing reports</b>: Peripheral edema<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Immediate-release formulations:</p><p><b>Very common</b> (10% or more): Micturition difficulties (up to 12.2%), menstrual disorders (up to 10.4%)</p><p><b>Common</b> (1% to 10%): Incontinence, sexual dysfunction</p><p><b>Frequency not reported</b>: Menstrual irregularities, urinary retention</p><p><b>Postmarketing reports</b>: Galactorrhea</p><p></p><p>Extended-release tablets:</p><p><b>Common</b> (1% to 10%): Difficulty in micturition, dysmenorrhea, premenstrual syndrome, sexual dysfunction</p><p><b>Uncommon</b> (0.1% to 1%): Urinary frequency, urinary incontinence</p><p><b>Postmarketing reports</b>: Galactorrhea<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Immediate-release formulations:</p><p><b>Very common</b> (10% or more): Sweating (up to 15.1%), rash (up to 11%)</p><p><b>Common</b> (1% to 10%): Dermatitis</p><p><b>Frequency not reported</b>: Pruritus</p><p><b>Postmarketing reports</b>: Photosensitivity reaction, Stevens-Johnson syndrome</p><p></p><p>Extended-release tablets:</p><p><b>Common</b> (1% to 10%): Pruritus, sweating increased</p><p><b>Uncommon</b> (0.1% to 1%): Clamminess, rash, urticaria</p><p><b>Postmarketing reports</b>: Stevens-Johnson syndrome<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Immediate-release formulations:</p><p><b>Very common</b> (10% or more): Nasal congestion (up to 17.4%)</p><p><b>Common</b> (1% to 10%): Hyperventilation, upper respiratory tract infection</p><p></p><p>Extended-release tablets:</p><p><b>Common</b> (1% to 10%): Allergic rhinitis, dyspnea, hyperventilation, nasal congestion, pharyngolaryngeal pain, upper respiratory tract infections</p><p><b>Uncommon</b> (0.1% to 1%): Choking sensation, dysphonia, epistaxis, rhinorrhea, sleep apnea syndrome<sup>[Ref]</sup></p><h3>Ocular</h3><p>Immediate-release formulations:</p><p><b>Very common</b> (10% or more): Blurred vision (up to 21%)</p><p><b>Rare</b> (0.01% to 0.1%): Increased intraocular pressure</p><p><b>Frequency not reported</b>: Diplopia</p><p></p><p>Extended-release tablets:</p><p><b>Common</b> (1% to 10%): Blurred vision</p><p><b>Uncommon</b> (0.1% to 1%): Mydriasis, photophobia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Immediate-release formulations:</p><p><b>Common</b> (1% to 10%): Muscle stiffness, muscle tone disorders, muscular cramps, muscular twitching, rigidity</p><p><b>Uncommon</b> (0.1% to 1%): Muscular weakness</p><p><b>Frequency not reported</b>: Musculoskeletal weakness</p><p></p><p>Extended-release tablets:</p><p><b>Common</b> (1% to 10%): Arthralgia, back pain, muscle cramps, muscle twitching, myalgia, pain in limb</p><p><b>Frequency not reported</b>: Increased muscle spasticity<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Immediate-release formulations:</p><p><b>Common</b> (1% to 10%): Infection</p><p></p><p>Extended-release tablets:</p><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Immediate-release formulations:</p><p><b>Common</b> (1% to 10%): Allergy</p><p><b>Postmarketing reports</b>: Angioedema</p><p></p><p>Extended-release tablets:</p><p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Immediate-release formulations:</p><p><b>Rare</b> (0.01% to 0.1%): Abnormal hepatic function tests, jaundice</p><p><b>Frequency not reported</b>: Elevated bilirubin, elevated hepatic enzymes</p><p><b>Postmarketing reports</b>: Hepatic failure, hepatitis</p><p></p><p>Extended-release tablets:</p><p><b>Postmarketing reports</b>: Hepatic failure, hepatitis, liver enzyme elevations<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Immediate-release formulations:</p><p><b>Postmarketing reports</b>: Gynecomastia, hyperprolactinemia</p><p></p><p>Extended-release tablets:</p><p><b>Postmarketing reports</b>: Gynecomastia, hyperprolactinemia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Niravam (alprazolam)." Schwarz Pharma, Mequon, WI. </p><p id="ref_2">2. "Product Information. Xanax (alprazolam)." Pharmacia and Upjohn, Kalamazoo, MI. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_5">5. "Product Information. Xanax XR (alprazolam)." Pfizer U.S. Pharmaceuticals Group, New York, NY. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>How long does Xanax last for / stay in your system?</li>
<li>Klonopin vs Xanax - How are they different?</li>
<li>How long does Xanax XR take to start working, and how long does it stay in your system?</li>
<li>What is Farmapram called in the US?</li>
<li>Ativan vs Xanax - What is the difference?</li>
<li>What does extended release (ER) mean?</li>
</ul><h2>More about Xanax XR (alprazolam)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>40 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: benzodiazepines</li>
<li>FDA Alerts (3)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Xanax XR Oral &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Xanax</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Panic Disorder</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>